|
||||||||||||||||||||||||||||||||||
[發(fā)表評(píng)論] [本類其他產(chǎn)品] [本類其他供應(yīng)商] [收藏] |
銷售商: 上海信裕生物科技有限公司 | 查看該公司所有產(chǎn)品 >> |
磷酸化絲裂原活化蛋白激酶1/2抗體ELISA=1:500-1000 IHC-P=1:200-800 IHC-F=1:100-500 Flow-Cyt=1μg /test IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in other applications.
產(chǎn)品編號(hào) bs-3016R
英文名稱 phospho-ERK1/2 (Thr202 + Tyr204)
中文名稱 磷酸化絲裂原活化蛋白激酶1/2抗體
別 名 ERK1 (phospho T202 + Y204); p-ERK1 (phospho T202 + Y204); Erk1 (pT202/pY204) + Erk2 (pT185/pY187); p-ERK1/2(T202/Y204); ERK 1; ERK 2; MK03_HUMAN; MK01_HUMAN; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK1; MAPK2; MGC20180; Microtubule associated protein 2 kinase; Mitogen activated protein kinase 1; Mitogen activated protein kinase 1; Mitogen activated protein kinase 2; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; MK01_MOUSE; p38; p40; p41; p41mapk; p42 MAPK; p42-MAPK; p42MAPK; p42MAPK; p44 ERK1; p44 MAPK; p44ERK1; p44ERK1; p44MAPK; p44MAPK; PRKM 1; PRKM 1; PRKM 2; PRKM 2; PRKM1; PRKM2; Protein kinase mitogen activated 1; Protein kinase mitogen activated 1; Protein kinase mitogen activated 2; Protein kinase mitogen activated 2; Protein tyrosine kinas.
磷酸化絲裂原活化蛋白激酶1/2抗體濃度為1mg/ml緩沖= 0.01m TBS(pH7.4)1%牛血清白蛋白,0.03% proclin300和50%甘油。背景:
該基因編碼的蛋白屬于一組顯然無(wú)效的泛素結(jié)合酶同系物。該基因產(chǎn)物含有卷曲螺旋結(jié)構(gòu)域的蛋白相互作用的胞漿蛋白,導(dǎo)致腫瘤的發(fā)生。該蛋白可能在細(xì)胞生長(zhǎng)和分化中起作用,起負(fù)生長(zhǎng)調(diào)節(jié)作用。該腫瘤易感基因的體外穩(wěn)態(tài)表達(dá)對(duì)于維持基因組穩(wěn)定性和細(xì)胞周期調(diào)控具有重要意義。磷酸化絲裂原活化蛋白激酶1/2抗體該基因的突變和選擇性剪接發(fā)生在乳腺癌的高頻率,表明乳腺癌的發(fā)生和/或進(jìn)展過程中出現(xiàn)缺陷。TSG101也與病毒蛋白含有一個(gè)萌芽晚主題P [圣] - a-p.這種互動(dòng)是必不可少的病毒粒子出芽等眾多逆轉(zhuǎn)錄病毒HIV-1 P6人泡沫病毒gag,HTLV-1插科打諢,以及埃博拉病毒VP40。又名:ESCRT我復(fù)雜的亞基表達(dá);ESCRT-I復(fù)合體亞基表達(dá);TSG101;TSG 10;TSG 101;tsg10;腫瘤易感基因10;腫瘤易感基因101;腫瘤易感基因101蛋白;腫瘤易感性蛋白;腫瘤易感性蛋白亞型3;23 vps23;ts101_human VPS。特異性:●兔多克隆抗體,親和純化的蛋白A●反應(yīng):人、小鼠、大鼠、狗、牛、馬、兔,!馣LH免疫原:共軛來自人TSG101蛋白合成肽!耦A(yù)測(cè)分子量:44kda。貯存:4度裝運(yùn),貯存于20度(避免重復(fù)凍融循環(huán))。磷酸化絲裂原活化蛋白激酶1/2抗體應(yīng)用:WB = 1:500-2000 ELISA = 1:500-1000 ihc-p = 1:400-800 ihc-f = 1:100-500如果= 1:100-500
在其它應(yīng)用程序中沒有測(cè)試。
最佳工作濃度必須由最終用戶確定。
Anti-β-Amyloid(1-42)β淀粉樣肽(1-42)抗體 規(guī)格:0.1ml/0.2ml支 產(chǎn)品應(yīng)用:WB ELISA IHC-P IHC-F Flow-Cyt ICC IF
Anti-Ang-Ⅱ (Angiotensin Ⅱ)血管緊張素II抗體 規(guī)格:0.1ml/0.2ml支 產(chǎn)品應(yīng)用:WB ELISA IHC-P IHC-F Flow-Cyt ICC IF
Anti-Angiotensin II receptor (AngⅡ R)血管緊張素Ⅱ受體抗體 規(guī)格:0.1ml/0.2ml支 產(chǎn)品應(yīng)用:WB ELISA IHC-P IHC-F Flow-Cyt ICC IF
Anti-ANGPTL1/ANG-1 (Angiopoietin-like Protein 1)血管位蛋白樣1/血管生成素樣蛋白-1抗體 規(guī)格:0.1ml/0.2ml支 產(chǎn)品應(yīng)用:WB ELISA IHC-P IHC-F Flow-Cyt ICC IF
Anti-ANGPTL2/ANG-2 (Angiopoietin-like Protein 2)血管位蛋白樣2/血管生成素樣蛋白-2抗體 規(guī)格:0.1ml/0.2ml支 產(chǎn)品應(yīng)用:WB ELISA IHC-P IHC-F Flow-Cyt ICC IF
Anti-ANGPTL4/ANG-4 (Angiopoietin-like Protein 4)血管位蛋白樣4/血管生成素樣蛋白-4抗體 規(guī)格:0.1ml/0.2ml支 產(chǎn)品應(yīng)用:WB ELISA IHC-P IHC-F Flow-Cyt ICC IF